Statements (58)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Research_Institute
|
gptkbp:addresses |
Genetic disorders
Chronic conditions Rare diseases |
gptkbp:affiliatedWith |
Universities
|
gptkbp:aimsTo |
Enhance quality of life
Reduce healthcare costs Improve treatment outcomes Develop gene therapies |
gptkbp:collaboratesWith |
Biotechnology companies
|
gptkbp:conducts |
Clinical trials
Preclinical studies |
gptkbp:contributedTo |
Medical research
|
gptkbp:develops |
Gene delivery systems
Gene_editing_techniques |
gptkbp:engagesIn |
Community outreach
|
gptkbp:focusesOn |
Gene therapy
|
gptkbp:hasEstablished |
Ethical guidelines
|
gptkbp:hasPart |
Research staff
Laboratory facilities Clinical facilities |
gptkbp:hasPublications |
Case studies
Clinical trial results Scientific reviews |
gptkbp:hosts |
Conferences
|
https://www.w3.org/2000/01/rdf-schema#label |
Gene Therapy Institute
|
gptkbp:innovation |
Personalized medicine
|
gptkbp:isActiveIn |
Gene therapy field
|
gptkbp:isDedicatedTo |
Scientific excellence
Ethical research practices |
gptkbp:isEngagedIn |
Translational research
|
gptkbp:isFocusedOn |
Innovative therapies
|
gptkbp:isInfluencedBy |
Biomedicine
|
gptkbp:isInvolvedIn |
Cell therapy
Regenerative medicine International collaborations Biomanufacturing Patient advocacy Tissue engineering Clinical applications |
gptkbp:isKnownFor |
Innovative treatments
|
gptkbp:isPartOf |
Healthcare_ecosystem
|
gptkbp:isRecognizedBy |
Regulatory bodies
|
gptkbp:isSupportedBy |
Non-profit organizations
Philanthropic contributions |
gptkbp:location |
Various locations
|
gptkbp:offers |
Clinical trials
|
gptkbp:partnerships |
Healthcare_providers
|
gptkbp:promotes |
Public awareness
|
gptkbp:provides |
Training programs
|
gptkbp:publishes |
Research papers
|
gptkbp:receivesFundingFrom |
Private donations
Government grants Pharmaceutical companies |
gptkbp:supports |
Patient care
|
gptkbp:utilizes |
Viral vectors
CRISPR technology Stem cells |